Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.
Tadarro L RichardsonAlese E HalvorsonAmber J HackstadtAdriana M HungRobert A GreevyCarlos G GrijalvaTom A ElasyChristianne L RoumiePublished in: Annals of internal medicine (2023)
VA Clinical Science Research and Development and supported in part by the Centers for Diabetes Translation Research.